课题基金 / 基金详情

Analysis of roles of tumor suppressor gene WT1 in human leukemogenesis.

Analysis of roles of tumor suppressor gene WT1 in human leukemogenesis.
抑癌基因WT1在人类白血病发生中的作用分析。
批准号:
09470230
负责人:
SUGIYAMA Haruo
金额:
$7.81万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

SUGIYAMA Haruo的其他基金

相似基金

相关文献

中文摘要
翻译
Wilms‘s肿瘤基因WT1被鉴定为与Wilms’s瘤有关的基因,Wilms‘s瘤是一种儿童肾脏肿瘤,被归类为肿瘤抑制基因。编码锌指转录因子的WT1基因抑制生长因子、p生长因子受体和其他一些基因的转录。我们已经报道了在新鲜白血病细胞中野生型WT1的高水平表达,而不考虑白血病的类型。此外,WT1反义寡聚物可特异性抑制白血病细胞的生长。这些结果提出了一种假设,即野生型WT1基因在造血祖细胞中发挥致癌作用,而不是抑癌基因功能,在白血病发生中发挥重要作用。为了证明这一假设,进行了一系列实验。32D c13是一种依赖白介素3的髓系祖细胞,在G-CSF刺激下可分化为成熟的中性粒细胞。但当野生型WT1基因在32D c13细胞中结构性表达时,细胞停止分化并继续增殖。此外,WP1感染的骨髓(BM)细胞在G-CSF作用下形成的CFU-GM、CFU-G和CFU-M集落明显多于对照BM细胞。
英文摘要
The Wilms' tumor gene WT1 was identified as a gene responsible for Wilms' tumor, a childhood kidney neoplasm and classified as a tumor suppressor gene. The WT1 gene encoding a zinc finger transcription factor represses transcription of growth factors, p growth factor receptors and some other genes. We have reported high levels of wild-type WT1 expression in fresh leukemic cells regardless of the types of leukemias. Furthermore, WT1 antisense oligomer specifically inhibited the growth of leukemia cells. These results have raised a hypothesis that the wild-type WT1 gene exerts an oncogenic rather than a tumor suppressor gene function in hematopoietic progenitor cells and plays an important role in leukemogenesis. To prove this hypothesis, a series of experiments were performed. 32D c13, an interleukin 3-dependent myeloid progenitor cell line, differentiates into mature neutrophils in response to G-CSF.However, when transfected wild-type WT1 gene was constitutively expressed in 32D c13 cells, the cells stopped differentiating and continued to proliferate in response to G-CSF.Furthermore, significantly more CFU-GM, CFU-G, and CFU-M colonies were formed in WP1-infected bone marrow (BM) cells than in control BM cells in response to G-CSF.These results supported our hypothesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inoue K.et al.: "Wilms'tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells." Blood. 91. 2969-2976 (1998)
Inoue K.等人:“维尔姆斯肿瘤基因(WT1)与造血祖细胞中的分化诱导信号竞争。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Inoue K.: "Aberrant overexpression of the Wilms tumor gene(WT1)in human leukemia." Blood. 89. 1405-1412 (1997)
Inoue K.:“人类白血病中维尔姆斯肿瘤基因(WT1)的异常过度表达。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sugiyama H.et al.: "Wilms tumor gene (WT1) mRNA is equally expressed in blast cells from acute myeloid leukemia and normal CD34+ progenitors (Response)." Blood. 90. 4230-4232 (1997)
Sugiyama H.等人:“Wilms 肿瘤基因 (WT1) mRNA 在急性髓性白血病和正常 CD34 祖细胞的母细胞中表达相同(响应)。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Inoue K.et al.: "Wilms'tumor gene(WT1)competes with differentiation-inducing signal in hematopoietic progenitor cells." Blood. 91. 2969-2976 (1998)
Inoue K.等人:“维尔姆斯肿瘤基因(WT1)与造血祖细胞中的分化诱导信号竞争。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Development of molecular diagnosis and molecule-targeted therapy for leukemia
    • 批准号:
      17015028
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $82.88万
    • 财政年份:
      2005
    • 负责人:
      SUGIYAMA Haruo
    • 依托单位:
    WT1 protein-targeted immunotherapy for leulemia
    • 批准号:
      15109007
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $76.13万
    • 财政年份:
      2003
    • 负责人:
      SUGIYAMA Haruo
    • 依托单位:
    Role of the Wilms' tumor gene WT1 in human leukemogenesis
    • 批准号:
      13470205
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      2001
    • 负责人:
      SUGIYAMA Haruo
    • 依托单位:
    The role of the tumor suppressor gene WT1 in human leukemogenesis.
    • 批准号:
      11470210
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.28万
    • 财政年份:
      1999
    • 负责人:
      SUGIYAMA Haruo
    • 依托单位:
    海外基金